Get access

Audiologic and temporal bone imaging findings in patients with sensorineural hearing loss and GJB2 mutations

Authors

  • Kenneth H. Lee MD, PhD,

    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Daniel A. Larson MD,

    1. University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Gordon Shott,

    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Brian Rasmussen,

    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Aliza P. Cohen MA,

    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Corning Benton MD,

    1. Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Mark Halsted MD,

    1. Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Daniel Choo MD,

    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    2. Department of Otolaryngology Head & Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • Jareen Meinzen-Derr PhD,

    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    2. Department of Otolaryngology Head & Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.
    3. Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    Search for more papers by this author
  • John H. Greinwald Jr. MD

    Corresponding author
    1. Hearing and Deafness Center, Division of Pediatric Otolaryngology/Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
    2. Department of Otolaryngology Head & Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.
    • Division of Pediatric Otolaryngology-Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2018, Cincinnati, OH 45229
    Search for more papers by this author

Abstract

Objectives/Hypothesis:

Our objectives were to determine genotype-phenotype correlations in patients with sensorineural hearing loss (SNHL) who undergo testing for GJB2 mutations and to examine the relationship of temporal bone anomalies seen on computed tomography (CT) and GJB2 mutations.

Study design:

We conducted a retrospective review of all children diagnosed with SNHL and who underwent GJB2 testing from 1997 to 2006.

Results:

Of 840 patients, 146 (17.4%) had mutations. Seventy-six (9.1%) had biallelic GJB2 mutations and 70 (8.3%) had heterozygous mutations. When biallelic mutations were categorized as missense or nonsense mutations, the presence of at least one missense mutation was associated with mild or moderate SNHL. Biallelic nonsense mutations were associated with severe to profound SNHL. Among patients with GJB2 mutations, those with heterozygous mutations (n = 14 [20%]) had a higher rate of asymmetric SNHL loss than those with biallelic mutations (n = 6 [7.9%], P = .03). Those with heterozygous mutations were more likely to experience progression than were those with biallelic mutations, though this difference was only marginally significant (26.5% vs. 12.3%, respectively; P = .06). Patients who were wild type for GJB2 were more likely to have an enlarged vestibular aqueduct (EVA) than were those with biallelic and heterozygous mutations (29% vs. 11.9%, respectively; P = .004). Compared to patients who were wild type, those with biallelic mutations had a significantly lower rate of EVA.

Conclusions:

This is the largest single-institution study of pediatric patients with GJB2 mutations and SNHL. The functional consequences of GJB2 mutations correlated with the degree of hearing loss. Patients with M34T mutations and/or mild SNHL had a low risk of progression. Temporal bone anomalies were uncommon in patients with GJB2 mutations. Laryngoscope, 119:554–558, 2009

Get access to the full text of this article

Ancillary